Literature DB >> 30677394

New insights on the cardiac safety factor: Unraveling the relationship between conduction velocity and robustness of propagation.

Patrick M Boyle1, William H Franceschi2, Marion Constantin3, Claudia Hawks4, Thomas Desplantez5, Natalia A Trayanova6, Edward J Vigmond7.   

Abstract

Cardiac conduction disturbances are linked with arrhythmia development. The concept of safety factor (SF) has been derived to describe the robustness of conduction, but the usefulness of this metric has been constrained by several limitations. For example, due to the difficulty of measuring the necessary input variables, SF calculations have only been applied to synthetic data. Moreover, quantitative validation of SF is lacking; specifically, the practical meaning of particular SF values is unclear, aside from the fact that propagation failure (i.e., conduction block) is characterized by SF < 1. This study aims to resolve these limitations for our previously published SF formulation and explore its relationship to relevant electrophysiological properties of cardiac tissue. First, HL-1 cardiomyocyte monolayers were grown on multi-electrode arrays and the robustness of propagation was estimated using extracellular potential recordings. SF values reconstructed purely from experimental data were largely between 1 and 5 (up to 89.1% of sites characterized). This range is consistent with values derived from synthetic data, proving that the formulation is sound and its applicability is not limited to analysis of computational models. Second, for simulations conducted in 1-, 2-, and 3-dimensional tissue blocks, we calculated true SF values at locations surrounding the site of current injection for sub- and supra-threshold stimuli and found that they differed from values estimated by our SF formulation by <10%. Finally, we examined SF dynamics under conditions relevant to arrhythmia development in order to provide physiological insight. Our analysis shows that reduced conduction velocity (Θ) caused by impaired intrinsic cell-scale excitability (e.g., due to sodium current a loss-of-function mutation) is associated with less robust conduction (i.e., lower SF); however, intriguingly, Θ variability resulting from modulation of tissue scale conductivity has no effect on SF. These findings are supported by analytic derivation of the relevant relationships from first principles. We conclude that our SF formulation, which can be applied to both experimental and synthetic data, produces values that vary linearly with the excess charge needed for propagation. SF calculations can provide insights helpful in understanding the initiation and perpetuation of cardiac arrhythmia.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiac electrophysiology; Cardiac excitability; Cardiac safety factor; Conduction velocity; Fibrosis; Sodium channel; Source-sink mismatch

Mesh:

Year:  2019        PMID: 30677394      PMCID: PMC6474757          DOI: 10.1016/j.yjmcc.2019.01.010

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  31 in total

1.  Computational tools for modeling electrical activity in cardiac tissue.

Authors:  Edward J Vigmond; Matt Hughes; G Plank; L Joshua Leon
Journal:  J Electrocardiol       Date:  2003       Impact factor: 1.438

2.  An intuitive safety factor for cardiac propagation.

Authors:  Patrick M Boyle; Edward J Vigmond
Journal:  Biophys J       Date:  2010-06-16       Impact factor: 4.033

3.  Model of reentrant ventricular tachycardia based on infarct border zone geometry predicts reentrant circuit features as determined by activation mapping.

Authors:  Edward J Ciaccio; Hiroshi Ashikaga; Riyaz A Kaba; Daniel Cervantes; Bruce Hopenfeld; Andrew L Wit; Nicholas S Peters; Elliot R McVeigh; Hasan Garan; James Coromilas
Journal:  Heart Rhythm       Date:  2007-05-04       Impact factor: 6.343

4.  A rabbit ventricular action potential model replicating cardiac dynamics at rapid heart rates.

Authors:  Aman Mahajan; Yohannes Shiferaw; Daisuke Sato; Ali Baher; Riccardo Olcese; Lai-Hua Xie; Ming-Jim Yang; Peng-Sheng Chen; Juan G Restrepo; Alain Karma; Alan Garfinkel; Zhilin Qu; James N Weiss
Journal:  Biophys J       Date:  2008-01-15       Impact factor: 4.033

5.  Directional characteristics of action potential propagation in cardiac muscle. A model study.

Authors:  L J Leon; F A Roberge
Journal:  Circ Res       Date:  1991-08       Impact factor: 17.367

6.  Heterogeneous gap junction remodeling in reentrant circuits in the epicardial border zone of the healing canine infarct.

Authors:  Candido Cabo; Jianan Yao; Penelope A Boyden; Shan Chen; Wajid Hussain; Heather S Duffy; Edward J Ciaccio; Nicholas S Peters; Andrew L Wit
Journal:  Cardiovasc Res       Date:  2006-07-12       Impact factor: 10.787

7.  Ca2+/calmodulin-dependent protein kinase II regulates cardiac Na+ channels.

Authors:  Stefan Wagner; Nataliya Dybkova; Eva C L Rasenack; Claudius Jacobshagen; Larissa Fabritz; Paulus Kirchhof; Sebastian K G Maier; Tong Zhang; Gerd Hasenfuss; Joan Heller Brown; Donald M Bers; Lars S Maier
Journal:  J Clin Invest       Date:  2006-11-22       Impact factor: 14.808

8.  Spiral waves and reentry dynamics in an in vitro model of the healed infarct border zone.

Authors:  Marvin G Chang; Yibing Zhang; Connie Y Chang; Linmiao Xu; Roland Emokpae; Leslie Tung; Eduardo Marbán; M Roselle Abraham
Journal:  Circ Res       Date:  2009-10-08       Impact factor: 17.367

9.  Structural correlate of atrial fibrillation in human patients.

Authors:  Sawa Kostin; Gabi Klein; Zoltan Szalay; Stefan Hein; Erwin P Bauer; Jutta Schaper
Journal:  Cardiovasc Res       Date:  2002-05       Impact factor: 10.787

10.  Relationships between resting conductances, excitability, and t-system ionic homeostasis in skeletal muscle.

Authors:  James A Fraser; Christopher L-H Huang; Thomas H Pedersen
Journal:  J Gen Physiol       Date:  2011-06-13       Impact factor: 4.086

View more
  7 in total

1.  Detection of Drug-Induced Torsades de Pointes Arrhythmia Mechanisms Using hiPSC-CM Syncytial Monolayers in a High-Throughput Screening Voltage Sensitive Dye Assay.

Authors:  Andre Monteiro da Rocha; Jeffery Creech; Ethan Thonn; Sergey Mironov; Todd J Herron
Journal:  Toxicol Sci       Date:  2020-02-01       Impact factor: 4.849

2.  Cardiomyocyte functional screening: interrogating comparative electrophysiology of high-throughput model cell systems.

Authors:  Simon P Wells; Helen M Waddell; Choon Boon Sim; Shiang Y Lim; Gabriel B Bernasochi; Davor Pavlovic; Paulus Kirchhof; Enzo R Porrello; Lea M D Delbridge; James R Bell
Journal:  Am J Physiol Cell Physiol       Date:  2019-10-02       Impact factor: 4.249

3.  Ephaptic Coupling Is a Mechanism of Conduction Reserve During Reduced Gap Junction Coupling.

Authors:  Joyce Lin; Anand Abraham; Sharon A George; Amara Greer-Short; Grace A Blair; Angel Moreno; Bridget R Alber; Matthew W Kay; Steven Poelzing
Journal:  Front Physiol       Date:  2022-05-05       Impact factor: 4.755

Review 4.  Fibrosis and Conduction Abnormalities as Basis for Overlap of Brugada Syndrome and Early Repolarization Syndrome.

Authors:  Bastiaan J Boukens; Mark Potse; Ruben Coronel
Journal:  Int J Mol Sci       Date:  2021-02-04       Impact factor: 5.923

Review 5.  Electrophysiological Substrate in Patients with Barlow's Disease.

Authors:  Pasquale Vergara; Savino Altizio; Giulio Falasconi; Luigi Pannone; Simone Gulletta; Paolo Della Bella
Journal:  Arrhythm Electrophysiol Rev       Date:  2021-04

6.  The Purkinje-myocardial junction is the anatomic origin of ventricular arrhythmia in CPVT.

Authors:  Daniel J Blackwell; Michela Faggioni; Matthew J Wleklinski; Nieves Gomez-Hurtado; Raghav Venkataraman; Chelsea E Gibbs; Franz J Baudenbacher; Shiaoching Gong; Glenn I Fishman; Patrick M Boyle; Karl Pfeifer; Bjorn C Knollmann
Journal:  JCI Insight       Date:  2022-02-08

Review 7.  Mechanisms of Arrhythmias in the Brugada Syndrome.

Authors:  Michiel Blok; Bastiaan J Boukens
Journal:  Int J Mol Sci       Date:  2020-09-25       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.